In recent years, multiple probiotics have been tested in randomized controlled trials for IBS (Irritable Bowel Syndrome), but due to differences in strain tested and methodology, making recommendations concerning which probiotics are beneficial for the management of IBS has been difficult to date.
A new well-conducted meta-analysis by renowned gastroenterology experts has been published in the most prominent journal for the field: Gastroenterology, the official journal of the American Gastroenterological Association.
In this study, the authors assessed three endpoints in IBS populations: global symptoms—abdominal pain—bloating, or distension.
Discover the key facts on the study and how S. cerevisiae CNCM I-3856 is now acknowledged as one of the most documented probiotic strains for IBS symptom management, specifically for abdominal pain.
Latest news & videos
- MenaQ7®
- Mobility & Joint
- News
- Jan 14, 2025
Vitamin K2: Debunking Myths and Understanding Benefits
Research consistently shows that while Vitamin K is crucial for normal blood coagulation, Vitamin...
- Adonat®
- Download
- News
- Jan 13, 2025
Adonat® Premium SAMe for Menopausal Women’s Well-Being
The S-adenosyl-L-methionine (SAMe) can be a versatile molecule in alleviating various symptoms associated with...
- News
- Quatrefolic®
- Reproduction & Women
- Jan 10, 2025
Quatrefolic® Approved in China for Maternal Nutrition: A Breakthrough for Pregnant and Lactating Women
The registration approval of Quatrefolic® by Chinese authorities marks a significant milestone for its...
